Application of SHAP values
CPT Pharmacometrics Syst Pharmacol. 2022;11:1100–1110
SYMPHONY on tour: Interview with Karina Meijer
Prof. dr. Karina Meijer is a haematologist at the University Medical Centre Groningen (UMCG). She is also one of the leaders of WP 9 of SYMPHONY, which researches the ethics of gene therapy for haemophilia. Why did you choose haematology? A lot of things that happen are simply by chance. [...]
SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
Journal of Thrombosis and Haemostasis - Wiley Online Library
Deep compartment models
CPT Pharmacometrics Syst Pharmacol. 2022;11:934–945
Replacement therapy in haemophilia A
Haemophilia. 2022;1–9.
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
TH Open 2022 Feb 3;6(1):e60-e69. doi: 10.1055/a-1760-0105. eCollection 2022 Jan.
Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice
Blood Advances 2021 Oct 26;5(20):4314-4325. doi: 10.1182/bloodadvances.2021005096.
Patient-reported outcomes in autosomal inherited bleeding disorders
Haemophilia. 2022;28:197–214
Persoonlijke Gezondheidsomgeving voor meer inzicht en regie
NVHP Faktor editie maart 2022 De volledige Faktor kan gelezen worden op de NVHP website